Characteristics and Outcomes of ST-Segment Elevation Myocardial Infarction Due to Left Main Coronary Artery Stenosis

Ramy Sedhom1, Mohamed Omer2, Mohamed Khedr3

  • 1Division of Cardiology, Loma Linda University Medical Center, Loma Linda, California.

PubMed

Insights

Left main coronary artery (LMCA) ST-elevation myocardial infarction (STEMI) incidence and cardiogenic shock (CS) rose from 2016-2022. Mortality remains high, exceeding 25% for LMCA STEMI patients.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Public Health

Background:

  • Limited data exists on ST-segment elevation myocardial infarction (STEMI) incidence and outcomes specifically from left main coronary artery (LMCA) lesions.
  • LMCA STEMI represents a critical subset of myocardial infarction with potentially severe consequences.

Purpose of the Study:

  • To investigate the trends in incidence and outcomes of STEMI caused by LMCA lesions.
  • To analyze the utilization of mechanical circulatory support, revascularization strategies, and intravascular imaging in LMCA STEMI patients.

Main Methods:

  • Utilized the Nationwide Readmissions Database to identify hospitalizations for LMCA STEMI between January 2016 and December 2022.
  • Analyzed in-hospital mortality, incidence of cardiogenic shock (CS), and treatment modalities including mechanical circulatory support, percutaneous coronary intervention (PCI), and intravascular imaging (IVI).

Main Results:

  • LMCA STEMI accounted for 0.3% of all STEMI hospitalizations, with a notable increase in incidence and associated cardiogenic shock (CS) over the study period.
  • Mechanical circulatory support was used in 78.8% of CS patients, with Impella use rising significantly. Revascularization via PCI was common (62.1%), but intravascular imaging (IVI) use remained low (18.3%) despite an increase.
  • All-cause in-hospital mortality was 25.5%, significantly higher in patients with CS (43.4%) compared to those without (11.4%).

Conclusions:

  • The incidence of LMCA STEMI and its complication, cardiogenic shock, have increased between 2016 and 2022.
  • Despite advances, intravascular imaging use in LMCA PCI is suboptimal. In-hospital mortality for LMCA STEMI remains high, with nearly half of patients experiencing CS and over a quarter dying during admission.

Related Concept Videos

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
361
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
812
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
215
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
220
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
474
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
592